Your browser doesn't support javascript.
loading
Vancomycin nephrotoxicity: A comprehensive clinico-pathological study.
Nachiappa Ganesh, Rajesh; Edwards, Angelina; El Zaatari, Ziad; Gaber, Lillian; Barrios, Roberto; Truong, Luan D.
Afiliación
  • Nachiappa Ganesh R; Department of Pathology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India.
  • Edwards A; Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas, United States of America.
  • El Zaatari Z; Division of Nephrology, Department of Medicine, Houston Methodist Hospital, Houston, Texas, United States of America.
  • Gaber L; Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas, United States of America.
  • Barrios R; Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas, United States of America.
  • Truong LD; Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas, United States of America.
PLoS One ; 19(3): e0295136, 2024.
Article en En | MEDLINE | ID: mdl-38452051
ABSTRACT

INTRODUCTION:

Vancomycin, a commonly prescribed antibiotic particularly in the setting of multi-drug resistant infections, is limited by its nephrotoxicity. Despite its common occurrence, much remains unknown on the clinicopathologic profile as well as the pathogenesis of vancomycin nephrotoxicity. Clinical studies included patients often with severe comorbidities and concomitant polypharmacy confounding the causal pathogenesis. Animal models cannot recapitulate this complex clinical situation. Kidney biopsy was not commonly performed.

METHODS:

To address this limitation, we studied 36 patients who had renal biopsies for acute kidney injury (AKI) for suspicion of vancomycin nephrotoxicity. Detailed renal biopsy evaluation, meticulous evaluation of clinical profiles, and up-to-date follow-up allowed for a diagnostic categorization of vancomycin nephrotoxicity (VNT) in 25 patients and absence of vancomycin nephrotoxicity (NO-VNT) in 11 patients. For careful comparison of these two groups, we proceeded to compile a clinicopathologic and morphologic profiles characteristic for each group.

RESULTS:

Patients with VNT had a characteristic clinical profile including a common clinical background, a high serum trough level of vancomycin, a rapidly developed and severe acute kidney injury, and a recovery of renal function often shortly after discontinuation of vancomycin. This clinical course was correlated with characteristic renal biopsy findings including acute tubulointerstitial nephritis of allergic type, frequent granulomatous inflammation, concomitant and pronounced acute tubular necrosis of nephrotoxic type, and vancomycin casts, in the absence of significant tubular atrophy and interstitial fibrosis. This clinico-pathologic profile was different from that of patients with NO-VNT, highlighting its role in the diagnosis, management and pathogenetic exploration of vancomycin nephrotoxicity.

CONCLUSION:

Vancomycin nephrotoxicity has a distinctive morphologic and clinical profile, which should facilitate diagnosis, guide treatment and prognostication, and confer pathogenetic insights.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Lesión Renal Aguda / Nefritis Intersticial Límite: Humans Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2024 Tipo del documento: Article País de afiliación: India

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Lesión Renal Aguda / Nefritis Intersticial Límite: Humans Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2024 Tipo del documento: Article País de afiliación: India